Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ABBOTT LABORATORIES ABT

Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the... see more

Recent & Breaking News (NYSE:ABT)

The Reason It Trades, What's Moving HES, ABT, TIP and LINE

Marketwired January 31, 2013

Before the Crowd, How We Found AA, ABT, ADSK and BAC

Marketwired January 29, 2013

AbbVie and Abbott under StockCall Scrutiny: Major Drug Manufacturers Look to Emerging Economies

PR Newswire January 28, 2013

Free Research Report on Ctrip.com International, Ltd., QUALCOMM Incorporated, Abbott Laboratories, Juniper Networks, Inc. and Lowe's Companies, Inc.

PR Newswire January 28, 2013

Abbott Reports Fourth-Quarter and Full-Year 2012 Results

PR Newswire January 23, 2013

Abbott and AbbVie Named to S&P Dividend Aristocrats Indices

PR Newswire January 21, 2013

Abbott and AbbVie Announce Investor Calls

PR Newswire January 14, 2013

The Reason It Trades, What's Moving AVNW, ABT, ZERO and SLB

Marketwired January 11, 2013

New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks

PR Newswire January 9, 2013

Abbott Initiates Clinical Trial of Absorb(tm) in the United States

PR Newswire January 8, 2013

The Real Story Behind ABT, HLF, PFE and GSK

Marketwired January 4, 2013

Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE Xpedition(tm) Drug Eluting Stent System

PR Newswire January 3, 2013

S&P 500 Index Gains the Most Since 2009 -- Fiscal Cliff Likely to Be Avoided

Marketwired January 3, 2013

Are Those Stocks, ABT, HEB, SKUL and TZYM, Oversold?

Marketwired January 3, 2013

Abbott Completes Separation of Research-Based Pharmaceuticals Business

Canada NewsWire January 2, 2013

Abbott Completes Separation of Research-Based Pharmaceuticals Business

PR Newswire January 2, 2013

Abbott and AbbVie to Present at Financial Conferences

PR Newswire December 21, 2012

AbbVie Set to Join S&P 100 & 500; Federated Investors Set to Join S&P MidCap 400; ITT Educational Services & Procera Networks to Join S&P SmallCap 600

PR Newswire December 20, 2012

Merger Monday boosts stock markets

Colin Cieszynski September 28, 2009